Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 92%
filed 2026-07-29
Item 1.01
Accuray entered into a Securities Purchase Agreement with TCW Asset Management Company LLC involving issuance of 55,000 shares of Series A Convertible Preferred Stock for $55 million ($15 million cash plus $40 million debt conversion), cancellation of approximately 27.6 million warrants, and amendment of the Financing Agreement. The transaction includes board designation rights for TCW (2 of 7 directors), consent rights over major corporate actions, and conversion rights at $0.50 per share, fundamentally representing a material change of control and recapitalization.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-29
Item 5.02
Beverly Huss and Anne LeGrand resigned from the Board effective July 29, 2026, in connection with the material financial restructuring agreement with TCW. The board size is being reduced from 8 to 7 directors as part of the governance restructuring accompanying the capital transaction.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-29
Item 2.02
First Northern Community Bancorp disclosed quarterly and six-month financial results for Q2 2026, reporting net income of $4.7 million for the quarter and $10.6 million for the six-month period, along with comprehensive financial metrics including earnings per share, balance sheet data, and performance ratios.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
Pebblebrook Hotel Trust issued a press release on July 29, 2026 announcing Q2 2026 financial results, including net income of $24.9 million, Same-Property Hotel EBITDA of $123.3 million (7.1% higher than Q2 2025), and Adjusted FFO per diluted share of $0.68.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-29
EX-99.1
This is a news release announcing Cenovus Energy's second-quarter 2026 financial and operating results, including adjusted funds flow of $5.0 billion, free funds flow of $3.8 billion, upstream production of 970.4 MBOE/d, and net earnings of $2.9 billion. The document presents comprehensive quarterly financial statements, operating metrics, and guidance updates—the hallmark of an earnings release. Material to investors as it discloses quarterly financial performance and revised full-year guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
Sensata Technologies disclosed its second quarter 2026 financial results via press release on July 29, 2026, as required under Item 2.02. The filing reports revenue of $990.6 million (up 5.0% YoY), operating income of $165.4 million (up 19.8% YoY), and EPS of $0.70 (up 70.7% YoY), along with six-month results and Q3 2026 guidance. This is a standard quarterly earnings announcement with material financial metrics that would affect investor assessment of the company's performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
This is a standard earnings release disclosing Teladoc Health's Q2 2026 financial results, including revenue of $606.9 million (down 4% YoY), net loss of $38.9 million ($0.21 per share), and adjusted EBITDA of $65.7 million (down 5% YoY). The press release is attached as Exhibit 99.1 and includes detailed segment performance, cash flow metrics, and forward guidance for Q3 and full-year 2026, which is the typical format and content of a material earnings disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
This is a clear earnings release disclosing Meridian Holdings' financial results for Q2 2026 and the first half of 2026. The filing explicitly states "On July 29, 2026, Meridian Holdings Inc. issued a press release disclosing its results of operations for the three and six-month periods ended June 30, 2026." The press release reports revenue of $50.2 million (up 16% YoY), net income of $2.2 million (second consecutive quarter of GAAP profitability), and adjusted EBITDA of $5.9 million (up 43% YoY), along with balance sheet metrics and segment performance details. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-29
Item 1.02
Rich Christensen, Chief Financial Officer, departed the Company effective July 31, 2026, with the termination of his Employment Agreement disclosed in Item 1.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 88%
filed 2026-07-29
Item 5.02
The Company appointed three executives and directors effective July 31, 2026: Zoran Milošević as Chief Executive Officer, William Scott as Chief Financial Officer (transitioning from Interim CEO while remaining Chairman), and Michael Prescott as an Independent Director, as part of a Board-led succession process to drive the next stage of global expansion.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
Capitol Federal Financial issued a press release on July 29, 2026 announcing preliminary financial results for the third quarter of fiscal year 2026, including net income of $23.6 million, net interest margin of 2.31%, and earnings per share of $0.19.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-29
Item 7.01
Capitol Federal Financial announced a quarterly cash dividend of $0.085 per share payable August 21, 2026, reflecting the Company's capital management strategy and historical dividend payments totaling $1.60 billion since 2010.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 98%
filed 2026-07-29
EX-99.1
The exhibit announces the appointment of David Sturgeon as Chief Financial Officer of RedCloud Holdings plc, effective August 1, 2026. This is a clear executive appointment of a named officer to a C-suite role at a recently-listed public company. The disclosure emphasizes his extensive experience at Nasdaq-listed companies and his expertise in SEC reporting, investor relations, and corporate governance — all material to a recently-listed, high-growth company's governance and financial leadership structure.
View raw filing on EDGAR →
8-K
Legal Other
confidence 75%
filed 2026-07-29
SurgePays discloses a Notice of Apparent Liability for Forfeiture (NAL) issued by the FCC to its subsidiary Torch Wireless on July 22, 2026, concerning alleged late submission of documents to the FCC. The filing clarifies that Torch cooperated with the FCC and disputes the NAL's basis, intending to seek its withdrawal or pursue legal remedies. This is a regulatory enforcement matter that does not fit the specific legal categories (material_litigation, cybersecurity_incident, covenant_breach) but represents a material regulatory event affecting the subsidiary's operations and potential financial exposure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-29
Item 1.01
Processa Pharmaceuticals completed a material merger with Vidya Therapeutics on July 28, 2026, acquiring Vidya's clinical-stage BTK inhibitor program (VT-7208) through a stock-for-stock transaction. Vidya shareholders received 558,398 shares of common stock and 142,744.100 shares of Series A Preferred Stock, with pre-transaction Processa shareholders diluted to approximately 0.9% post-transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-29
Item 3.02
Processa completed a concurrent private placement of approximately $200 million in Series A convertible preferred stock (163,774.679 shares at $1,221.19 per share) to institutional investors under Section 4(a)(2), with PIPE investors owning approximately 52.6% of Processa on a fully-diluted basis post-closing.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-07-29
Item 5.02
Sheila Gujrathi, M.D., was appointed to Processa's Board of Directors effective immediately after the merger closing on July 28, 2026, bringing extensive biopharmaceutical industry experience as part of the leadership changes resulting from the Vidya acquisition.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-29
The 6-K discloses progress on Genius Group's application for dual listing on the Australian Securities Exchange (ASX), including receipt of initial feedback from ASX and an estimated completion timeline in Q4 2026. This is a material operational/strategic milestone affecting the company's capital structure and market access, but does not fit the specific event categories (it is neither M&A, a discrete financing event, nor a routine administrative disclosure). The disclosure reflects active engagement with a major regulatory process that would affect investor assessment of the company's strategic direction and future liquidity.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-07-29
FOXO Technologies' subsidiary Vector BioSource has entered into a definitive agreement to acquire four U.S.-based blood collection centers from Grifols Bio Supplies, Inc. The filing explicitly states this is a material acquisition expected to add over $10 million in net revenues in the twelve months following closing. The transaction involves a purchase of assets with upfront cash payment and potential earnout provisions, structured as a material acquisition of operating assets that will expand Vector's business capabilities and market access through FDA licensure.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-07-29
The filing discloses an amendment to the Company's Certificate of Incorporation (Item 5.03) that eliminated voting rights of Class E Common Stock, approved by majority stockholders via written consent on June 24, 2026 and filed effective July 29, 2026. This is a governance event involving charter amendment and shareholder action, but does not fit the specific categories of auditor change, shareholder vote results, or executive appointment/departure. The elimination of voting rights for a class of stock is material to investors' assessment of governance structure and shareholder rights.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-07-29
EX-99.1
VivoPower announced a US$50 million private investment in public equity (PIPE) structured as convertible preference shares converting at US$7.50 per share into Class A Ordinary Shares, with participation from institutional investors and entities associated with the CEO. This is a classic dilutive issuance of convertible securities that will result in equity dilution upon conversion, material to investors assessing capital structure and ownership.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-29
The filing discloses a material acquisition transaction under Item 8.01 (Other Events). Cycurion entered into an Agreement and Plan of Merger on May 7, 2026 with Halo Privacy, Inc. and havenX, Inc., with a scheduled closing by July 31, 2026 (the "Outside Date"). The disclosure indicates that as of the filing date (July 29, 2026), the transaction is unlikely to close due to a Key Employee's refusal to commence employment post-closing and Halo/havenX's failure to deliver required audited financial statements and closing deliverables. This represents a material M&A event in jeopardy, which would significantly affect investor assessment of the registrant's strategic position and financial prospects.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-07-29
The 8-K discloses quarterly financial results for the second quarter of 2026 via Item 2.02 (Results of Operations and Financial Condition), with a press release attached as Exhibit 99.1. The press release reports diluted EPS of $0.88 (up 6.1% from Q1), net earnings of $5.4 million, and key performance metrics including ROA of 1.35% and ROE of 13.23%. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-07-29
Galmed terminated a license agreement with Yissum dated June 28, 2021, effective July 31, 2026, resulting in reversion of all licensed technology rights and cessation of patent funding obligations. The company stated the termination was part of efforts to "consolidate operations, reduce costs and focus resources on the commercialization of Colospan and continued development of Aramchol." This is a material operational/strategic decision affecting the company's technology portfolio and R&D focus, but does not fit the specific categories of M&A activity, workforce reduction, or material litigation.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-29
The filing discloses completion of a disposition of a wholly owned subsidiary (Mahaotiaodong Information Technology Company) on July 9, 2026, pursuant to an Equity Transfer Agreement signed July 1, 2026. This is a material change of control event involving sale of 100% of a subsidiary's shares, classifiable as a completed disposition under Item 1.02 / 2.01 of the 8-K taxonomy (or equivalent 6-K disclosure). The nominal consideration (US$100) does not diminish materiality of divesting an entire subsidiary.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-07-29
Celularity received notice from Nasdaq on July 23, 2026, that it no longer complies with the minimum bid price requirement (Nasdaq Listing Rule 5450(a)(1)) because its Class A common stock closing bid price fell below $1.00 per share for 30 consecutive business days. The company has 180 calendar days until January 19, 2027, to regain compliance or face potential delisting. This is a classic delisting-risk disclosure under Item 3.01.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-07-29
The filing discloses entry into a definitive merger agreement on July 29, 2026, under which MiMedx Group, Inc. will acquire all outstanding shares of Sanara MedTech Inc. in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. Item 1.01 explicitly covers "Entry into a Material Definitive Agreement," and the merger consideration ($33 cash + 0.4735 MDXG shares per SMTI share) and strategic rationale (expansion of surgical footprint, nearly doubling surgical revenue, $20M+ cost synergies) clearly constitute a material acquisition transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-29
The filing discloses an unregistered sale of 32,110 shares of common stock to a service provider at $3.27 per share under Section 4(a)(2) of the Securities Act. This is a classic dilutive issuance—an unregistered equity sale relying on the private offering exemption. Item 3.02 is the designated disclosure item for such transactions, and the language explicitly references the exemption from registration requirements.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-29
EX-99.1
This press release announces the commencement of drilling operations at the K-29 well on IEC's Kruh Block in Sumatra, described as "the first of two new planned wells" in 2026. The spudding and drilling commencement represent a material operational milestone in the company's core exploration and production activities. While not fitting a discrete named event type (not M&A, not a financial obligation, not a workforce action), this is clearly a material operational/strategic development that advances the company's development program and would affect a reasonable investor's assessment of execution progress on its principal assets.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-29
The filing discloses a private placement of 250,000 shares of common stock at $4.80 per share for approximately $1.2 million in aggregate proceeds under a Private Placement Agreement with Pinnacle Partners Inc., with the shares issued in reliance on Regulation S (offshore transaction). This is a classic unregistered equity issuance disclosed under both Item 1.01 (Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), which is material to investors as it represents dilution and capital raising activity.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-07-29
HWH International received a Nasdaq deficiency notice on May 29, 2026 for failing to meet the minimum stockholders' equity requirement of $2.5 million under Listing Rule 5550(b)(1), with reported equity of only $2,078,220. Although Nasdaq granted an extension on July 24, 2026 to regain compliance by August 31, 2026, this is a material delisting risk disclosure. The filing explicitly addresses the company's non-compliance with continued listing standards and the remedial actions required to avoid delisting.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-29
The filing discloses that Shane Gleason, the Company's Chief Commercial Officer, has been notified that his position has been eliminated, with his last day of employment on July 31, 2026. This is a clear departure of a named officer, disclosed under Item 5.02, and constitutes a material executive departure event.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-29
The filing discloses entry into a securities purchase agreement on July 24, 2026, under which NextNRG issued a $2 million senior secured convertible note to an institutional investor, with gross proceeds of approximately $1.8 million received at closing. While the note is convertible into common stock (triggering Item 3.02), the primary event and financial obligation created is the debt issuance itself—a senior secured note bearing 12% interest, maturing October 24, 2026, with a payment premium of 50% of principal due at maturity. The company also granted security interests in substantially all assets and subsidiary guaranties, evidencing a material direct financial obligation.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-29
HCW Biologics entered into a Securities Purchase Agreement on July 29, 2026, to issue 618,682 units comprising 218,682 shares of common stock and 400,000 pre-funded warrants, plus common warrants contingent on stockholder approval, for approximately $1.6 million in gross proceeds. This is a classic private placement of equity securities by an emerging growth company raising capital, disclosed under Items 1.01 and 3.02, with the pre-funded warrants and common warrants representing significant dilution to existing shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-07-29
Item 1.01
The filing discloses merger activity ("the Mergers") with stock consideration to be issued to counterparties, explicitly referencing Item 1.01 (entry into material agreements/M&A) and Item 3.02 (unregistered equity issuances). The securities are being issued in reliance on Section 4(a)(2) exemption, indicating a private transaction. This is a material acquisition or merger event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 75%
filed 2026-07-29
The filing's primary substantive content is Item 5.07, which discloses the results of FuboTV's 2026 Annual Meeting of Stockholders held on July 28, 2026, including voting results for six proposals (director elections, auditor ratification, executive compensation advisory votes, equity plan amendment, and certificate amendment). While the filing also contains secondary disclosures of an executive appointment (Alisa Bowen to the board) and equity plan amendment approval, the central event reported is the shareholder vote results with detailed voting tallies for each proposal.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-07-29
The filing discloses a new Executive Employment Agreement with Adam Levy (President and CEO) effective July 23, 2026, replacing his prior 2025 agreement. The disclosure details compensatory arrangements including: base salary of $375,000, discretionary and performance-based cash bonuses tied to EBITDA targets, and a grant of 160,000 stock options with a five-year term and $0.647 exercise price. While the agreement also includes severance provisions, the principal focus is on the compensation structure and equity grant, making this an exec_compensation event under Item 5.02(e).
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-29
The filing discloses under Item 5.02 that Thomas Gallagher was terminated as Chief Revenue Officer on July 28, 2026 without cause. This is a clear executive departure event. The termination of a named officer responsible for revenue generation is material to investors' assessment of the company's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-29
The filing discloses conversion notices from three directors (Casamento, Demesmin, and Goldman) electing to convert remaining outstanding principal amounts totaling approximately $466,000 under Convertible Bridge Notes into common stock. While the conversions are conditional on the stock price reaching $0.50 and insider trading compliance, this represents a material dilutive issuance of equity that will occur upon satisfaction of those conditions. The event is disclosed under Item 8.01 (Other Events) rather than Item 3.02, but the substance is a dilutive equity issuance by insiders.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-07-29
The 6-K discloses an At The Market Offering Agreement under which Fusion Fuel Green PLC may offer and sell Class A Ordinary Shares through H.C. Wainwright & Co., LLC. The Company has already sold 256,597 shares for approximately $2.8 million and filed a prospectus supplement on July 29, 2026 relating to the offer and sale of up to $6.6 million in additional Class A Ordinary Shares. This is a dilutive equity issuance that would materially affect a reasonable investor's assessment of share dilution and capital structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-29
EX-99.1
Anfield Energy released a Preliminary Economic Assessment (PEA) of its uranium and vanadium mining project, evaluating the reactivation of the Shootaring Canyon mill with feed from the Velvet Wood and Slick Rock mines, including mineral resource estimates, mining methods, processing recovery, and economic analysis prepared by qualified persons under National Instrument 43-101.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-07-29
Item 1.01
Bandwidth entered into a third amendment to its credit agreement effective July 25, 2026, which increases the permitted restricted payments basket from $20 million to $40 million (or 20% of TTM EBITDA), materially modifying the terms of the existing credit facility and enhancing the Company's financial flexibility.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
Bandwidth issued a press release on July 29, 2026 reporting Q2 2026 financial results, including revenue of $220 million (up 22% YoY), Adjusted EBITDA of $28 million (up 27% YoY), and raised full-year 2026 guidance.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-29
Item 5.02
R. Brandon Asbill, General Counsel and Secretary, notified the Company on July 24, 2026 of his decision to retire effective December 31, 2026, with an orderly transition planned and no disagreement with the Company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
The Company announced financial results for the thirteen and twenty-six weeks ended June 26, 2026 via press release dated July 29, 2026. The disclosure includes GAAP net income of $33.8 million ($0.76 per diluted share) for Q2 2026 versus $21.2 million ($0.49 per diluted share) in Q2 2025, net sales growth of 12.9% to $1.17 billion, and full-year 2026 guidance. This is a standard quarterly earnings release with material financial results and forward guidance that would affect a reasonable investor's assessment of the registrant's performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-29
Item 2.02
Mechanics Bancorp issued a press release on July 29, 2026 reporting second quarter 2026 financial results, including net income of $57.7 million ($0.25 per diluted share), total assets of $21.2 billion, and strong capital ratios, with completion of the HomeStreet merger integration.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-29
Item 2.02
Regional Management Corp. issued a press release on July 29, 2026 announcing financial results for the three and six months ended June 30, 2026, with quarterly net income of $8.2 million and diluted EPS of $0.85, along with year-to-date results showing 14% net income growth and 17% EPS growth year-over-year.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-29
Item 8.01
The Board of Directors declared a quarterly cash dividend of $0.30 per share payable on September 16, 2026, announced on July 29, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-29
Item 2.02
Alkami issued a press release on July 29, 2026 announcing Q2 2026 financial results, disclosing GAAP total revenue of $129.8 million (up 15.9% YoY), GAAP net loss of $(8.9) million (improved from $(13.6) million), and Adjusted EBITDA of $19.4 million (up from $11.9 million), along with forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-29
Item 8.01
This disclosure describes the issuance and closing of Commercial Mortgage Pass-Through Certificates totaling approximately $816.85 million ($706.575M public + $110.275M private) by Citigroup Commercial Mortgage Trust 2026-MFAM1 on July 29, 2026. The filing details the underwriting agreement, certificate purchase agreement, and net proceeds applied to purchase mortgage loans. While structured as a securitization rather than traditional debt, the certificates represent direct financial obligations backed by mortgage loans and constitute a material creation of new financial obligations requiring 8-K disclosure.
View raw filing on EDGAR →